Lila Wroblewska

Liliana Wroblewska is currently serving as the Director of Synthetic Biology at Asimov since April 2023. Previously, Wroblewska held significant positions at Pfizer, including Associate Research Fellow and Senior Principal Scientist from July 2014 to April 2023. Wroblewska's academic background includes postdoctoral research at the Massachusetts Institute of Technology and Princeton University, as well as a fellowship at the Georgia Institute of Technology. Wroblewska earned a Ph.D. in computational biology from both Georgia Institute of Technology and University at Buffalo, following a Master's degree in chemistry from the University of Warsaw. Early career experience includes research assistant roles at the Institute of Physics, Polish Academy of Sciences, and The Nencki Institute of Experimental Biology.